drugset / Trial / NCT00002342

A Study of Tecogalan Sodium

NCT00002342 ↗

Phase 1 Completed Daiichi Pharmaceuticals
Treatment

Summary

To evaluate the safety of different doses and dosing regimens of tecogalan sodium (DS-4152) and to establish the MTD at each of the different dosing schedules.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Tecogalan Unknown — Intravenous